{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:17:14Z","timestamp":1775553434891,"version":"3.50.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate the efficacy and safety of second uterine curettage in lieu of chemotherapy for patients with low-risk, nonmetastatic gestational trophoblastic neoplasia (GTN) and to evaluate whether response to second curettage is independent of patient age, World Health Organization (WHO) risk score, registration human chorionic gonadotropin (hCG) level, lesion size, and depth of myometrial invasion measured on ultrasound examination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This was a cooperative group multicenter prospective phase II study. Prestudy testing included quantitative hCG level, pelvic ultrasonography, and chest radiography. Patients were categorized according to WHO risk scoring criteria (low risk with a score of 0\u20136).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Sixty-four women with newly diagnosed low-risk, nonmetastatic GTN were enrolled. Four patients were excluded. Twenty-four patients (40%) (lower 95% confidence limit 27.6%) were cured after second curettage. An additional two patients (3%) achieved a complete response but did not complete follow-up. Overall, 26 of 60 patients were able to avoid chemotherapy. Surgical failure was observed in 34 women (59%) and was more common in women 19 years old or younger or 40 years old or older. One case of grade 1 uterine perforation was successfully managed by observation. Four grade 1 and one grade 3 uterine hemorrhages were reported. New metastatic disease (lung) was identified in one of these women after second curettage. In three patients (surgical failures), the second curettage pathology was placental site trophoblastic tumor, and it was placental nodule in one additional patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Second uterine curettage as initial treatment for low-risk, nonmetastatic GTN cures 40% of patients without significant morbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, https:\/\/clinicaltrials.gov\/, NCT00521118.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000001554","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T16:35:50Z","timestamp":1471624550000},"page":"535-542","source":"Crossref","is-referenced-by-count":69,"title":["Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia"],"prefix":"10.1097","volume":"128","author":[{"given":"Raymond J.","family":"Osborne","sequence":"first","affiliation":[]},{"given":"Virginia L.","family":"Filiaci","sequence":"additional","affiliation":[]},{"given":"Julian C.","family":"Schink","sequence":"additional","affiliation":[]},{"given":"Robert S.","family":"Mannel","sequence":"additional","affiliation":[]},{"given":"Kian","family":"Behbakht","sequence":"additional","affiliation":[]},{"given":"James S.","family":"Hoffman","sequence":"additional","affiliation":[]},{"given":"Nick M.","family":"Spirtos","sequence":"additional","affiliation":[]},{"given":"John K.","family":"Chan","sequence":"additional","affiliation":[]},{"given":"John A.","family":"Tidy","sequence":"additional","affiliation":[]},{"given":"David S.","family":"Miller","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0090-8258(80)90060-8","article-title":"Pretreatment curettage; a predictor of chemotherapy response in gestational trophoblastic neoplasia","volume":"10","author":"Berkowitz","year":"1980","journal-title":"Gynecol Oncol"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/00016348709103641","article-title":"Repeat curettage after evacuation of hydatidiform mole. An appraisal","volume":"66","author":"Lao","year":"1987","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/00016348809004280","article-title":"The value of endometrial curettage in the follow-up of hydatidiform mole","volume":"67","author":"Flam","year":"1988","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/0002-9378(90)90907-O","article-title":"Diagnostic and therapeutic curettage in gestational trophoblastic disease","volume":"162","author":"Schlaerth","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl XXVI","key":"R5-20230711","first-page":"17","article-title":"The role of second dilation and curettage in trophoblastic disease and the incidence of pregnancy in the first year after diagnosis","volume":"73","author":"Lorigan","year":"1996","journal-title":"Br J Cancer"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/gyno.2000.5839","article-title":"Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy","volume":"78","author":"Tidy","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1521-6934(03)00091-9","article-title":"Role of surgery and radiation therapy in the management of gestational trophoblastic disease","volume":"17","author":"Soper","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ygyno.2004.08.045","article-title":"The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease","volume":"95","author":"Pezeshki","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2005.06.032","article-title":"The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey","volume":"99","author":"van Trommel","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2005.08.001","article-title":"The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey","volume":"99","author":"Garner","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R11-20230711","first-page":"566","article-title":"Clinical response to a second uterine curettage in patients with low-risk gestational trophoblastic disease","volume":"59","author":"Yarandi","year":"2014","journal-title":"J Reprod Med"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1200\/JCO.2010.30.4386","article-title":"Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study","volume":"29","author":"Osborne","year":"2011","journal-title":"J Clin Oncol"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0140-6736(00)01324-6","article-title":"False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations","volume":"355","author":"Rotmensch","year":"2000","journal-title":"Lancet"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/000456328502200305","article-title":"Comparison of the analytical characteristics and clinical usefulness in tumour monitoring of fifteen hCG(-beta) immunoassay kits","volume":"22","author":"Thomas","year":"1985","journal-title":"Am Clin Biochem"},{"key":"R15-20230711","first-page":"285","article-title":"FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee","volume":"77","year":"2002","journal-title":"Int J Gynaecol Oncol"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1521-6934(03)00073-7","article-title":"Staging and classification of gestational trophoblastic disease","volume":"17","author":"Hancock","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2007.03.010","article-title":"Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in the Netherlands","volume":"106","author":"Kerkmeijer","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.AOG.0000136099.21216.45","article-title":"Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy","volume":"104","author":"Wolfberg","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/(SICI)1097-0258(19981030)17:20<2301::AID-SIM927>3.0.CO;2-X","article-title":"Optimal flexible designs in phase II clinical trials","volume":"17","author":"Chen","year":"1998","journal-title":"Stat Med"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2307\/2531294","article-title":"Confidence limits for probability of response in multi-stage phase II clinical trials","volume":"41","author":"Atkinson","year":"1985","journal-title":"Biometrics"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/sj.bjc.6605529","article-title":"The management and outcome of women with post-hydatidiform mole \u2018low-risk\u2019 gestational trophoblastic neoplasia, but hCG levels in excess of 100,000 IUI(-1)","volume":"102","author":"McGrath","year":"2010","journal-title":"Br J Cancer"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.ygyno.2013.04.126","article-title":"Treatment of low-risk gestational trophoblastic neoplasia: a probabilistic decision analysis model","volume":"130","author":"Reade","year":"2013","journal-title":"Gynecol Oncol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201609000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T15:04:21Z","timestamp":1689087861000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201609000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001554","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726620114.793558474","asserted-by":"object"}]},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}